Peter Stephens
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- Cancer Genomics and Diagnostics 4
- Oncology 4
- PARP inhibition in cancer therapy 3
- Co-authors
- Nicola J. Curtin (3 shared papers)Fiona K. Middleton (2 shared papers)Tao Chen (1 shared paper)Ruth Plummer (4 shared papers)David J Thomson (1 shared paper)Marie L. Foegh (1 shared paper)Vaishali S. Dixit (1 shared paper)William Hollingworth (1 shared paper)
- Journals
- Annals of Oncology (4 papers)The Lancet Oncology (2 papers)British Journal of Cancer (2 papers)European Journal of Cancer (2 papers)Molecular Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Peter Stephens
15 papers receiving 623 citations
Peter Stephens's Hit Papers
Peers
Comparison fields: 5 of 49
- Cancer Research 228
- Oncology 149
- Pulmonary and Respiratory Medicine 98
- Molecular Biology 185
- Economics and Econometrics 31
Countries citing papers authored by Peter Stephens
This map shows the geographic impact of Peter Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stephens more than expected).
Fields of papers citing papers by Peter Stephens
This network shows the impact of papers produced by Peter Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stephens. The network helps show where Peter Stephens may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Stephens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial Hit paper breakdown → | 2020 | 300 |
| 2 | 2011 | 144 | |
| 3 | 2020 | 64 | |
| 4 | 2015 | 33 | |
| 5 | 2014 | 28 | |
| 6 | 2014 | 21 | |
| 7 | 2015 | 19 | |
| 8 | 2012 | 11 | |
| 9 | 2017 | 5 | |
| 10 | 2015 | 3 | |
| 11 | 2016 | 3 | |
| 12 | 2017 | 3 | |
| 13 | 2014 | 2 | |
| 14 | 2017 | 2 | |
| 15 | 2016 | 1 |
About Peter Stephens
Peter Stephens is a scholar working on Cancer Research, Oncology, Economics and Econometrics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 639 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), DNA Repair Mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers), Pharmaceutical Economics and Policy (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Melanoma and MAPK Pathways (2 papers), Lung Cancer Treatments and Mutations (1 paper) and Health Services Management and Policy (1 paper). The work is most often cited by research in Cancer Research (228 citations), Oncology (149 citations), Pulmonary and Respiratory Medicine (98 citations), Molecular Biology (185 citations) and Economics and Econometrics (31 citations). Peter Stephens has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Nicola J. Curtin, Fiona K. Middleton, Tao Chen, Ruth Plummer, David J Thomson, Marie L. Foegh, Vaishali S. Dixit, William Hollingworth, Debashis Sarker and Sharon McGonigle. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, British Journal of Cancer, European Journal of Cancer and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.